The reported failure "clotting outlet side" occurred during the transport of the patient.The patient was infected with covid-19.Covid-19 diseases can be associated with intravascular coagulation activation, microcirculation disorders and increased risk of thromboembolism despite good systemic anticoagulation.Due to the high risk of spreading the sars-cov-2 virus outside the healthcare environment, a technical investigation of this hls set is not possible as the laboratory of maquet cardiopulmonary (b)(4) is not suitable for who risk group 3.Furthermore, no external laboratory could be found that could carry out the investigation on our behalf.The clotting outlet side is visual on the provided picture and could be confirmed.As the failure is clearly visible in the pictures the failure could be confirmed.A similar case was already investigated under complaint #: (b)(4) on 2020-06-05: as stated in the investigation report of ot # (b)(4) clots could be found inside the oxygenator.The most probable root cause for the increased pressure drop are clots in the oxygenator leading to a blockage, and thus an extension of the diffusion path lowering the oxygenating performance.According to the risk assessment (hls set advanced 5.0 / hls set advanced 7.0, dms # (b)(4), v26) following causes could lead to coagulation: de-airing luer lock connection too loose.Air remains in or enters the circuit ; hemostasis; air or blood remains in luer lock access port; too low anticoagulation; too low at level, effect of heparin is too limited; protamine sulfate enters the hls set; administration of substitution of congealable substance such as plateles; (consumption) coagulopathy; thrombocytopenia.Device history record (dhr) was performed, and there were no references found, which are indicating a nonconformance of the product in question.The reported failure "clotting outlet side" occurred during the transport of the patient and could be confirmed.The occurrence rate was calculated for the reported issue and it was determined that this is not a systemic issue.Therefore, no remedial action is required.The occurrence rate related to the reported issue is currently being monitored as part of maquet cardiopulmonarys trending program, and additional investigations, or corrections will be implemented in case of adverse trending.
|
It was reported from a customer from poland that during the transport of the patient with implanted ecmo-cardiohelp-i + hls, the hls module have clotted.The standard procedure of filling the system was used (1500 ml nacl + 5000 international units of heparin).Parameters after implantation of the ecmo system: part: 88 mmhg, p ven: - 78 mm hg, p int: 124; delta p: 36.After 20 min of procedure (during transport of ambulance of the patient to ecmo center).Appeared an increase pressure inside oxygenator, and increase delta p value, and the same time decrease blood flow, deficiency gas exchange.The hls set was replaced with a new one.No indication of actual or potential for harm or death reported.Patient (b)(6) y old diagnosis: covid -19.Complaint id: (b)(4).
|